Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract

Nature Medicine

Volumn 8, Issue 1, 2002, Pages 54-60

  Chang, Jun ^a   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; IMMUNITY; LUNG PARENCHYMA; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-2; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ANIMALIA; MURINAE; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES;

EID: 0036152463     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0102-54     Document Type: Article

References (35)

1. Epidemiology of acute lower respiratory disease in children
2. Serious respiratory tract disease caused by respiratory syncytial virus: Prospects for improved therapy and effective immunization
3. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults
4. Risk of primary infection and reinfection with respiratory syncytial virus
5. Repeated infections with respiratory syncytial virus
6. Immunity to and frequency of reinfection with respiratory syncytial virus
7. + T-cells
8. Cytotoxic T-cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus
9. Cytotoxic T-cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus
10. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection
11. + lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice
12. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T-cells during experimental virus infection
13. Virus-specific CD8+ T-cells in primary and secondary influenza pneumonia
14. Class I major histocompatibility complex-restricted T lymphocyte recognition of the influenza hemagglutinin. Overlap between class I cytotoxic T lymphocytes and antibody sites
15. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection
16. Distinct types of lung disease caused by functional subsets of antiviral T-cells
17. + T-cells secreting Th1 or Th2 cytokines
18. + T-cells
19. Serial triggering of many T-cell receptors by a few peptide-MHC complexes
20. Viral immune evasion due to persistence of activated T-cells without effector function
21. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists
22. Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA
23. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates
24. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract
25. Prevention of T-cell anergy by signaling through the γc chain of the IL-2 receptor
26. Partial T-cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T-cell anergy
27. Infectivity of respiratory syncytial virus by various routes of inoculation
28. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages
29. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice
30. Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection
31. Identification of the respiratory syncytial virus-induced immunosuppressive factor produced by human peripheral blood mononuclear cells in vitro as interferon-α
32. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
33. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children
34. Phenotypic analysis of antigen-specific T lymphocytes
35. Counting antigen-specific CD8 T-cells: A reevaluation of bystander activation during viral infection